US FDA declines to approve Grace Therapeutics' drug for a type of stroke
23/04/2026 18:19
April 23 (Reuters) - Grace Therapeutics GRCE.O said on Thursday the U.S. Food and Drug Administration declined to approve its drug for a rare type of stroke. (Reporting by Puyaan Singh in Bengaluru; Editing by Tasim Zahid) ((Puyaan.Singh@thomsonreuters.com;))
Recent news on Grace Therapeutics
See all newsBrief: Grace Therapeutics - Selling Stockholders May Resell Up To 4,761,904 Shares Of Common Stock - SEC Filing
Grace Therapeutics Q1 net loss widens on impairment charges
Grace Therapeutics falls after FDA declines to approve stroke drug
NASDAQ RESUMED AT 01:57 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:52 PM